Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Very early researchLooking for participantsNCT06891703
What this trial is testing

[18F]ACI-15916 PET in α-synucleinopathies

Who this might be right for
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA 46
Testing effectiveness (Phase 2)Study completedNCT00878254
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle-Cell Lymphoma
University of Miami 25
Not applicableUnknownNCT02778607
What this trial is testing

PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK

Who this might be right for
Progressive Supranuclear Palsy (PSP)Corticobasal DegenerationMultiple System Atrophy (MSA)
University College, London 900
Not applicableLooking for participantsNCT02194816
What this trial is testing

Modifiable Variables in Parkinsonism (MVP)

Who this might be right for
Parkinson's DiseaseParkinsonismMSA - Multiple System Atrophy+6 more
Bastyr University 2,000
Not applicableStudy completedNCT07121608
What this trial is testing

Exploring Dental Anxiety in Special Needs Patients: A Comparison of I-MDAS and Malay MDAS

Who this might be right for
Dental Anxiety
University of Malaya 56
Testing effectiveness (Phase 2)Study completedNCT00038610
What this trial is testing

Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 54
Not applicableLooking for participantsNCT06236789
What this trial is testing

Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Yonsei University 60
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Testing effectiveness (Phase 2)Ended earlyNCT00698009
What this trial is testing

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00006032
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)Active Not RecruitingNCT06706622
What this trial is testing

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
H. Lundbeck A/S 401
Not applicableStudy completedNCT03299907
What this trial is testing

COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BM3R)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Centre Hospitalier Universitaire de Besancon 5,263
Testing effectiveness (Phase 2)Study completedNCT01146548
What this trial is testing

Fluoxetine in Multiple System Atrophy Patients

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 87
Not applicableLooking for participantsNCT06072105
What this trial is testing

Medical Decision Making in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Medical University Innsbruck 92
Not applicableStudy completedNCT01889693
What this trial is testing

Imaging of Atherosclerosis With 68Ga-MSA

Who this might be right for
AtherosclerosisNoninvasive Imaging of Atherosclerosis
Korea University 60
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Not applicableActive Not RecruitingNCT05453058
What this trial is testing

Observational Study in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
H. Lundbeck A/S 90
Not applicableActive Not RecruitingNCT04253392
What this trial is testing

RETHINK REFLUX Registry

Who this might be right for
Gastroesophageal Reflux
Ethicon Endo-Surgery 500
Not applicableUnknownNCT06890377
What this trial is testing

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Load More Results